SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-004280
Filing Date
2024-03-28
Accepted
2024-03-28 17:14:01
Documents
34
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20231231x10k.htm 10-K 2405166
2 EX-4.3 tmb-20231231xex4d3.htm EX-4.3 30473
3 EX-23.1 tmb-20231231xex23d1.htm EX-23.1 1811
4 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 15724
5 EX-31.2 tmb-20231231xex31d2.htm EX-31.2 15718
6 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 7766
7 EX-32.2 tmb-20231231xex32d2.htm EX-32.2 7759
8 GRAPHIC tmb-20231231x10k001.jpg GRAPHIC 53038
9 GRAPHIC tmb-20231231x10k003.jpg GRAPHIC 51214
10 GRAPHIC tmb-20231231x10k005.jpg GRAPHIC 36870
11 GRAPHIC tmb-20231231x10k006.jpg GRAPHIC 22762
12 GRAPHIC tmb-20231231x10k007.jpg GRAPHIC 57813
13 GRAPHIC tmb-20231231x10k009.jpg GRAPHIC 80926
14 GRAPHIC tmb-20231231x10k010.jpg GRAPHIC 26856
15 GRAPHIC tmb-20231231x10k011.jpg GRAPHIC 71272
16 GRAPHIC tmb-20231231x10k012.jpg GRAPHIC 94129
17 GRAPHIC tmb-20231231x10k013.jpg GRAPHIC 32546
18 GRAPHIC tmb-20231231x10k014.jpg GRAPHIC 17852
19 GRAPHIC tmb-20231231x10k015.jpg GRAPHIC 15877
20 GRAPHIC tmb-20231231x10k016.jpg GRAPHIC 16724
21 GRAPHIC tmb-20231231x10k017.jpg GRAPHIC 17338
22 GRAPHIC tmb-20231231x10k018.jpg GRAPHIC 18400
23 GRAPHIC tmb-20231231x10k019.jpg GRAPHIC 17674
24 GRAPHIC tmb-20231231x10k020.jpg GRAPHIC 60902
25 GRAPHIC tmb-20231231x10k022.jpg GRAPHIC 101746
26 GRAPHIC tmb-20231231x10k023.jpg GRAPHIC 65603
27 GRAPHIC tmb-20231231x10k024.jpg GRAPHIC 73143
28 GRAPHIC tmb-20231231x10k025.jpg GRAPHIC 62895
29 GRAPHIC tmb-20231231x10k026.jpg GRAPHIC 77001
30 GRAPHIC tmb-20231231x10k027.jpg GRAPHIC 60535
31 GRAPHIC tmb-20231231x10k028.jpg GRAPHIC 60983
32 GRAPHIC tmb-20231231x10k030.jpg GRAPHIC 59754
33 GRAPHIC tmb-20231231x10k031.jpg GRAPHIC 41043
34 GRAPHIC tmb-20231231x10k032.jpg GRAPHIC 89951
  Complete submission text file 0001558370-24-004280.txt   4396641
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41929 | Film No.: 24800339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)